Fomento de Construcciones y Contratas SA (FCC)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 10.30 |
|---|---|
| 52-week range | 10.10 – 13.36 |
| Return, 1 month / 3 months | −3.9% / −12.4% |
| Return, 1 year / 3 years | −6.9% / +35.4% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 19.6% |
| Worst drawdown (1 year) | -20.7% |
| Average daily value traded | 0.20M EUR |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fomento de Construcciones y Contratas, known as FCC, is a Spanish group active in construction and infrastructure. It builds roads, railways, tunnels and public works, and it also runs environmental services such as waste collection, treatment and disposal, together with water management for towns and industry. Its customers are mainly public authorities and private clients in Spain and other countries, and the company is based in Madrid.
The shares are listed on the Madrid Exchange in Spain under the code FCC, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fomento de Construcciones y Contratas SA (FCC) trades on the Madrid Exchange in Spain. It last closed at EUR 10.30 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 136 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.9% and over the last three months it fell 12.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.3% | ||
| From 52-week high | -22.4% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.4% | ||
| 6-month return | -3.4% | ||
| 12-month return, skipping the last month | -3.1% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 19.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.7% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.20M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | −3.9% |
| 3 months | −12.4% |
| 6 months | −3.4% |
| 1 year | −6.9% |
| 3 years | +35.4% |
| 5 years | +54.8% |
Signals
| 50-day / 200-day average | 10.76 / 11.00 |
|---|---|
| Golden / death cross (60 days) | Death, 14 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.23 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Jul 2026 | EUR 0.5000 |
| 18 Jun 2025 | EUR 0.4050 |
| 2 Jul 2024 | EUR 0.3761 |
| 3 Jul 2023 | EUR 0.2893 |
| 20 Jun 2022 | EUR 0.2315 |
| 6 Jul 2021 | EUR 0.2315 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.